In conclusion, factors including ALT, MetS, gut microbiota, oxidative stress, and adipose tissue inflammation collectively influence the progression of MASLD/NAFLD and CVD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.